Long-term Outcomes in Men with Stable PSA During 5-α Reductase Inhibitor Therapy After Negative Prostate Biopsy: Population-based Study. [PDF]
Ventimiglia E +7 more
europepmc +1 more source
Autologous Micrograft Technology (AMT) and Finasteride for the Management of Androgenic Alopecia - A Systematic Review and Meta-Analysis of Their Efficacy and Safety. [PDF]
Ellerby A, Knudsen R.
europepmc +1 more source
Body mass index as a potential confounder in dutasteride and fertility studies. [PDF]
Akbari AR, Alam B, Ageed A.
europepmc +1 more source
Association between insulin resistance and prostate volume: A 4-year analysis from the Reduction by Dutasteride of Prostate Cancer (REDUCE) Trial. [PDF]
Daniels JP +6 more
europepmc +1 more source
Efficacy and Safety of Low-Dose (0.2 mg) Dutasteride for Male Androgenic Alopecia: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase III Clinical Trial. [PDF]
Lee S +13 more
europepmc +1 more source
A Randomized, Double-Blind, Placebo and Active Controlled Phase II Study to Evaluate the Safety and Efficacy of Novel Dutasteride Topical Solution (0.01%, 0.02%, and 0.05% w/v) in Male Subjects With Androgenetic Alopecia. [PDF]
Panuganti VK +6 more
europepmc +1 more source
Assessing the Efficacy of Multimodal Therapy in Nonsurgical Hair Restoration for Noncicatricial Alopecia: A Retrospective Study. [PDF]
Manakchand KK, Maheshwari S, Kumar A.
europepmc +1 more source
Efficacy of Skin Patting and Iontophoresis with Dutasteride Gel in Male and Menopausal Female Androgenetic Alopecia: A Pilot Study. [PDF]
Cedirian S +7 more
europepmc +1 more source
Global stagnation and misaligned priorities in BPH drug development: a 25-year landscape analysis of clinical trial registries. [PDF]
Lv Z +10 more
europepmc +1 more source

